Home
/ ARKAY
/ Competitors

ARKAY Competitors and Similar CompaniesClear all

ARKAY's competitors and similar companies include Sensulin, MannKind Corporation, Pila Pharma and BIOTON.

	ARKAY ARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes.	Sensulin Sensulin is a biotechnology company developing insulin for diabetes.	MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.	Pila Pharma Pila Pharma is a clinical-stage pharmaceutical company.	BIOTON Bioton is a biotech company whose major therapeutic area is diabetes.
Founding Date	Founding Date 2014	Founding Date 2011	Founding Date 1991	Founding Date 2014	Founding Date 1989
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma
Locations	Locations Windsor, US HQ	Locations Oklahoma City, US HQ San Diego, US	Locations Westlake Village, US HQ Danbury, US	Locations Malmö, SE HQ	Locations Macierzysz, PL HQ
Employees	Employees 1	Employees 8	Employees 39513% increase	Employees 9	Employees 361
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $349m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) zł282.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $26.8m (FY, 2025)	Cost of goods N/A	Cost of goods zł157.1m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $322.2m (FY, 2025)	Gross profit N/A	Gross profit zł128.4m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $5.9m (FY, 2025)	Net income N/A	Net income zł3.4m (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 3.1m	Total funding raised $ 200m	Total funding raised N/A	Total funding raised N/A